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Abstract—The development of the β− based radio-guided
surgery aims to extend the technique to those tumours where
surgery is the only possible treatment and the assessment
of the resection would most profit from the low background
around the lesion, as for brain tumours. Feasibility studies on
meningioma and gliomas already estimated the potentiality of
this new treatment. To validate the technique, a prototype of the
intraoperative probe detecting β− decays and specific phantoms
simulating tumour remnant patterns embedded in healthy tissue
have been realized. The response of the probe in this simulated
environment is tested with dedicated procedures. This document
discusses the innovative aspects of the method, the status of the
developed intraoperative β− detecting probe and the results of
the preclinical tests.
I. INTRODUCTION
THE main advantage of the radio-guided surgery (RGS)technique exploiting β− radiation [1], [2], compared to
the traditional RGS using γ radiation [3], is a more favourable
ratio between the signal coming from the tumor and the rest
of the body. Conversely to the tracers with γ emitters, pure
β− radionuclides emit electrons which penetrate only a few
millimeters of tissue and produce scarce gamma radiation (the
bremsstrahlung contribution above 100keV being less than
0.1%) resulting in a very low background on the lesion signal.
Operating in a low background environment allows the
development of a handy and compact probe which, detecting
particles emitted locally, provides a clearer delineation of mar-
gins of the lesioned tissue. The RGS technique applicability
can therefore be extended also to cases with large uptake of the
tracer from healthy organs next to the lesion, minimizing the
radiotracer activity to be administered with obvious extremely
positive implications for the patients. Low exposure of the
medical team is also expected [1].
Brain tumors are one of the clinical application that would
most profit from the technique with β− radiation since a
complete removal of the tumor is critical to reduce relapse and
other RGS techniques are limited by the significant uptake of
the healthy brain. Meningiomas have been identified as the first
clinical case of interest for the technique validation because
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of their sensitivity to DOTATOC [4], a synthetic analogue
of somatostatin, that can be labelled with 90Y, a pure β−
radionuclide [5]. The 90Y half-life (64 h) and electron energy
spectrum (endpoint: 2.28 MeV) make this isotope suitable for
nuclear medicine applications and, in particular, for β− RGS
due to absence of γ emission. A study [6] of the potentiality
of the proposed RGS technique was performed using PET
diagnostic exams of patients affected by meningioma after
administration of 68Ga-DOTATOC (the uptake can be assumed
independent from the linked radionuclide). The study of the
uptake of the radiotracer nearby the lesion showed that a
tumor-non-tumor ratio (TNR) greater than 10 is observed in
almost all the cases and a detailed simulation of the intraoper-
ative probe allowed predictions of the RGS performance that
resulted as very promising. Similar conclusions were recently
achieved on neuro-endocrine tumors [7].
To implement and validate this innovative RGS technique,
we have developed and characterized an intraoperative probe
detecting β− decays. Moreover, we have realized specific
phantoms simulating tumour remnant pattern embedded in
healthy tissue and developed dedicated test procedures to
investigate the response of the probe in this simulated en-
vironment. This article describes the developed intraoperative
β− detecting probe and its performance and the results of the
preclinical tests.
II. THE β− INTRAOPERATIVE PROBE
Fig. 1. Image of the intraoperative β− probe.
The first prototype of the intraoperative probe detecting
β− decays (Fig. 1) was designed a compact device with
high sensitivity to low energy electrons, directional detection
and fast response (few seconds) compatible with the surgical
activity. The required target spatial resolution is fixed by the
typical volume (0.1 ml) of a surgical tumour residual.
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The radiation sensitive element of the β− probe is a
small scintillator tip made of commercial poly-crystalline
para-terphenyl doped to 0.1% in mass with diphenylbutadi-
ene [8] manufactured by Detec-Europe. This material was
adopted, after a detailed study [9], due to its high light
yield (∼3 times larger than typical organic scintillators), non-
hygroscopic property, and low density that minimizes the
sensitivity to photons. Different detector sizes were tested: the
best configuration resulted in a cylinder of 5 mm in diameter
and 3 mm in height.
The scintillator tip is shielded from radiation coming from
the sides by a black PVC ring with external diameter of
11 mm. A 10 μm-thick aluminium front-end sheet covers the
detector window to ensure light tightness. This assembly is
mounted on top of an easy-to-handle aluminum cylindrical
body (diameter 8 mm and length 14 cm).
In order to avoid the risk of patients coming into contact
with electrical devices, the scintillation light is guided by four
50 cm long optical fibres outside the probe to a Hamamatsu
H10721-210 photo-multiplier tube (PMT). This photo-sensor
module has an integrated high voltage power supply circuit
requiring an input voltage as low as 5 V, making this device
compatible with the surgical environment. Finally, the read-
out electronics and the logic board are housed in a compact
box that wirelessly connects to a remote monitor to display
the counting rate.
III. CHARACTERIZATION OF THE β− INTRAOPERATIVE
PROBE
The detecting performances of the developed intraoperative
probe are studied in laboratory using different source topolo-
gies and emitting radionuclides.
A. Sensitivity to β− decays
The probe sensitivity in detecting electrons from β− decays
is measured with a point-like 90Sr source with nominal activity
of 370 Bq (Sr-source). The 90Sr spectrum is made of two
components in secular equilibrium: the Sr β− decay to 90Y
and the subsequent β− decay of the daughter. The latter
component is exactly the one proposed for this application.
The rate measured by the probe is 3.8·105 cps/MBq resulting
in a detection efficiency of 40% of the β− decay products of
the decay chain 90Sr/90Y.
A relevant parameter for the definition of the probe sensitiv-
ity is the detectable β− energy threshold that is the minimal
kinetic energy of the electron that reaches the probe and is
detected. To evaluate this threshold, a vertical scan over the
Sr-source has been performed measuring the rate with both the
source and the probe in water for several distances between
the two (“scan in water”). The presence of increasing amounts
of water dumps the β− energy spectrum in a known way and
the minimum amount of water for which no signal is observed
allows the inference of the detection threshold. Fig. 2 shows
the measured rate as a function of the probe distance from the
source at high distances: the probe counting rate is compatible
with the dark noise rate at 8.5 mm over the source.
Fig. 2. Large distance tail of the vertical scan over the Sr-source in water.
The blue horizontal line represents the dark counting rate.
To evaluate the electron energy loss along this path and the
residual energy of the electron approaching to the probe, a
Monte Carlo simulation based on FLUKA code [10] is used.
The FLUKA software fully simulates the energy spectrum
emitted by the point-like Sr source, the energy deposition in
water and the probe. Then, the energy spectrum of electrons
reaching the detector volume is evaluated at different distances
from the source and the “theoretical” rate is evaluated by
calculating the integral of the electrons having an energy
greater than a certain threshold, varying it from 300 to 600 keV
(consistent with what expected for a 2 MeV electron crossing
8 mm thickness of water). To estimate the energy threshold
which best reproduces the data, a χ2 test on point by point
basis is performed and by means of its minimization the value
of 487±33 keV for the energy threshold is obtained. That
allows us to conclude that the probe shows a high sensitivity
for electrons with energy above 500 keV and it is, therefore,
largely efficient (>80% according to the efficiency mentioned
above) in the energy range of the electrons emitted by 90Y,
which is the radionuclide that would be exploited for the RGS.
B. Spatial resolution
To study the capability of the probe to reconstruct active
spots, the detector is mounted on a motorized linear actuator
ensuring position accuracy of 1.5 μm and horizontal scans are
performed over point-like and extended sources.
The scan over the point-like Sr-source (Fig. 3) shows how
spatial resolution depends on the distance between the probe
tip and the surface. The reconstructed profiles measured at
distances ranging from 350 μm to 1.8 mm are fitted using a
Gaussian distribution obtaining σ between 2.8 and 4.4 mm.
The scan over the extended source (Fig. 4), instead, explores
the discovery power of the probe in a more realistic simulation
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Fig. 3. Profiles of the point-like Sr-source reconstructed by the probe at
different distances from the source.
Fig. 4. Lateral scan of a 1.4 kBq, 0.1 ml, 90Y phantom. Gaussian and linear
fits are for the signal and dark count rate respectively. See text for the band
definition.
of a radio-labelled tumour residual. A cylindrical phantom
with volume of 0.1 ml (diameter: 6.0 mm, height: 3.5 mm) is
filled with a saline solution with 90Y radionuclide of 1.4 kBq
activity, comparable to those administered for diagnostic pur-
poses. The profile reconstructed by the probe is obtained with
an horizontal scan of 1.5 mm steps and 10 s per position
and a distance between the probe and the phantom surface
of 100 μm. The probe is able to correctly identify the active
spot with a signal discriminating threshold S/N>5, where S
is the number of detected events and N is the number of dark
counts, and the real phantom dimension is reconstructed with
S/N>20.
C. Background rejection capability
The usage of pure β− emitting tracers allows the operation
with low radiation background, the residual being mainly
due to photons coming from the Bremsstrahlung radiation
of the electrons penetrating the tissue. The abundance of the
expected Bremsstrahlung radiation in the tissue as a function
Fig. 5. Energy spectrum (50-2000 keV, 10 keV interval) of 90Y
Bremsstrahlung photons in water.
of the photon energy is shown in Fig. 5 as computed with a
simulation of a 90Y source in water [11].
The sensitivity of the probe to these photons is measured
using three point-like sources: 133Ba emitting photons with
energy ranging from 80 to 350 keV, 137Cs with gamma
emission at Eγ=662 keV and 60Co with Eγ1=1170 keV and
Eγ2=1330 keV. To avoid signal from electrons in the case
of Cs decays, three copper layers with 350 μm thickness are
inserted in sequence between the source and the probe tip,
and the measurements are repeated at each step. The counts
as measured by the probe are shown in the Fig. 6 for the
three sources. Except for the first measure on the Cs source,
introducing the copper absorbers implies a very small decrease
in rate compatible with the attenuation in copper and the
change in geometrical acceptance.
The sensitivity to the photons emitted by the 133Ba source
is below 10−5, whereas for the γs from the 137Cs and 60Co
sources the sensitivity is still below 10−4. These measurements
allow us to conclude that the intraoperative β− probe is not
sensitive to the Bremsstrahlung photons and therefore the
effectiveness of the RGS technique would not be affected by
this background.
IV. PRECLINICAL TESTS ON SPECIFIC PHANTOMS
To estimate the performances of the technique, the probe
is tested on specific phantoms reproducing finite size menin-
gioma remnants embedded in healthy brain tissue with a TNR
as expected in a real clinical case. The same set-up allows
going through different kinds of interfaces and visual/acoustic
feedback to identify which one could best assist the surgeon
in the search for infected residuals.
Fig. 6. Probe sensitivity to photons emitted by three different sources: 60Co
Eγ1=1170 keV Eγ2=1330 keV, 137Cs Eγ=662 keV, 133Ba Eγ ranging from
80 to 350 keV. The measurements are repeated after insertions of copper layers
with thickness of 350 μm between the source and the probe tip to absorb the
electronic component of the Caesium emissions.
A. Realization of the phantoms
The surgical environment is simulated saturating conve-
niently shaped cuttings of a commercially available sponge
(Wettex Classic by Vileda R©) with leftover of the 90Y-
DOTATOC administered to patients during normal clinical
activity. The liquid source is diluted to reach the mass and
concentration (10 kBq/ml) allowed by law for the transport
and usage of this β emitter without special constraints.
The sponge is made of 65% cellulose and 35% cotton fibres
packed as 20×20 cm wide and 2 mm thick dry sheets. The
relevant parameters driving our choice were:
• water absorbency (as measured by us on small samples);
• ease of obtaining a sharp and precise cut even with few
millimetre wide complex shapes;
• capability of a sample to regain its original dimensions
after a wetting-drying cycle.
To radio-protect operators, the phantoms are set up and used
within a 10 mm thick PMMA glove box.
With this technique, both wet or dry surfaces can be
produced depending on the scope of the test:
• dry phantoms are used to test the neat physics detector
performances (e.g. sensitivity to active spots, capability
of profile reconstruction);
• wet surfaces are suitable for studying and optimizing the
probe usage in a more realistic environment where, for
example, tip contamination might occur adding a random
background to the signal coming from the tissues.
The simplest assembly made with this technique is shown in
Fig. 7: a 5 mm diameter circular cutting simulating a 0.05 ml
tumour residual is inserted inside a larger (20 mm diameter)
ring reproducing the nearby healthy tissue. A third round
shape (disk) is eventually used to reproduce the presence of
further healthy tissues above or under the hot spot. Different
TNR between the tumour and the surrounding healthy tissue
are realised drenching the cuttings, up to saturation, with the
properly diluted 90Y solution. The elements are then dried and
combined to shape the topology of interest (Fig. 8).
Fig. 7. Assembling of a phantom simulating a tumour residual of 0.05 ml
embedded in surrounding (the ring) and underneath (the disk) healthy tissue.
Fig. 8. Varying position and activity (white: non-active tissue, yellow:
active tissue) of the assembly elements the discovery potential of the probe
can be tested on surfaces reproducing, even if schematically, some possible
combinations of cancerous residual location and TNR occurring during
surgery.
The nominal activity of any phantom is inferred from the
activity of the 90Y-DOTATOC vial at the time of delivery and
the dilution factor of the bath prepared to drench the samples.
The relative activity of the final dried phantoms is individually
measured before forming the assembly.
B. Active spot identification
A scan over the described assembly is performed fixing the
probe to a XZ motorised system. The X linear actuator runs the
probe over the phantom in 1 mm steps, with a measurement
time of 10 s per position, while the Z actuator is used to set
the tip to surface distance with a precision of 1.5 μm.
The different configurations are analysed in terms of false-
positive probability, i.e. the probability that the signal (cps)
emitted by an healthy tissue is incorrectly flagged by the probe
as tumour residual. In the actual case, this flag will be set
in real time by the system comparing the signal measured
over the tissue under investigation and the patient reference
background previously measured over their healthy tissue.
The probability of false-positive then depends on the probe
efficiency, the time to response and the actual TNR.
An example of a scan with an indication of the false-positive
probability is shown in Fig. 9. The horizontal lines indicate
the threshold (in cps) level over which at 90%, 95% and
99% confidence level (C.L.) the underlying area is flagged
as “tumour” with a measure lasting 1 s or 10 s.
Fig. 9. Scan over two assemblies with a probe tip-surface distance next
to zero. The left phantom simulates a 0.5 ml tumour surrounded by a same
thickness healthy tissue with a TNR of 10 (as observed in patients affected
by meningioma), the second assembly is an isolated residual (non-active
surrounding tissue).
Fig. 10 and 11 show the same measurement performed
on different tumour-health tissue patterns (fixed the specific
activity and the TNR) that might affect the discovery potential
of the probe.
These evaluations are performed in a neat and well known
configuration, whereas the surgical environment might intro-
duce some perturbations as, for example, a contamination of
the probe tip coming into contact with the wet active tissue.
Such effect can be evaluated directly from the scan shown
in Fig. 9 adding, via software, an extra background to the
measure up to the minimum TNR that makes still detectable
the hot spot. The study shows that the probe is able to correctly
identify the active spot also in case of TNR as low as 2 with a
99% C.L. and a time of measure of 10 s. That means that an
eventual contamination would not be a problem if monitored
with frequent background calibration during the operation.
Moreover, these results imply that the RGS technique with
β− decays would be effective also in case of patients with a
lower TNR compared to those affected by meningioma, and
therefore they are a confirm that the RGS could be extended
to clinical case of interest with an eventual uptake of the
radiotracer in the nearby healthy organs [6].
C. Minimum detectable tumour residual
A different phantom pattern is used to simulate and study
the evolution of the probe response while removing an ex-
tended tumour area aiming at the identification of the mini-
mum detectable residual. For this purpose the assembly shown
in Fig. 12 is used. A scan over the whole strip is repeated
reducing the tumoural area by removing a tile at once starting
from the wider one (5 mm). At each iteration the assembly is
packed again to always keep the tumour area enclosed between
healthy tissues.
The scan over the full 15 mm long tumour phantom is
shown in Fig. 13. Following the scan from the right to the
Fig. 10. Scan over two assemblies with a probe tip-surface distance close to
zero realized to study the sensitivity of the probe to a 0.5 ml hot spot masked
by side and beneath emitting (TNR=10) healthy tissue.
Fig. 11. Scan over two assemblies with a probe tip-surface distance equal to
zero to test the sensitivity of the probe to a hot spot hidden under an emitting
(TNR=10) healthy tissue.
Fig. 12. The phantom prepared to simulate the progress of a surgical removal
of a tumour is made by a strip (blue) of seven tiles of different sizes and
charged at the tumour uptake. A sequence of scans is performed removing
a strip at each iteration to study the minimum detectable residual. At the
beginning and the end of this assembly two tiles (green) ten times less active
define the boundary of the healthy tissue surrounding the tumour.
left the experimental shape is read as follow: the cps counts
start from zero (the probe is outside the scanning area) and
increase as the probe goes over the healthy tissue. The small
plateau at 30 cps defines the background level of this measure.
Approaching the tumour phantom, the counts increase up to
plateau at about 250 cps lasting as much as the probe sensitive
area is fully illuminated by the tumour area. As soon as the
sensitive detector exits the last tumour tile the rate goes back
to that of the healthy tissue.
The response measured reducing the tumour thickness to
3 mm and 2.5 mm are shown in Fig. 14 and Fig. 15 respec-
tively. In both cases the tumour margins are clearly identified
once the activity of the surrounding healthy tissue is known.
The smallest residual tested in this measure, obtained re-
ducing by 5 mm the length of the 2.5 mm tile, has a volume
of 0.03 ml. The corresponding signal is shown in Fig. 15.
V. CONCLUSION
We report on the performance of the first prototype of
the intraoperative probe purposely designed to exploit the
newly proposed radio-guided surgery with β− decays. The
low density and the high light yield of the para-terphenyl
scintillator allow the development of a very compact device
with a good sensitivity to electrons in the range of the 90Y
decays and almost transparent to the bremsstrahlung photons.
The first results obtained experimenting the probe on point-
like and extended 90Y sources highlight the potentiality of this
approach in all the issues relevant in this field: millimetric
remnants discovery potential, spatial resolution, fast response,
dose administered to the patient, operators safety.
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Fig. 13. A scan over a 15×10 mm2 tumour activated phantom. The yellow
area indicate the position of the tiles between the two healthy tissue phantoms.
The limited lateral shield makes the probe sensitive to the approaching active
area about 4 mm before the detector goes over the hot tiles.
Fig. 14. Scan over a 3 mm wide tumour tile phantom. Since the width of
the phantom is smaller than the sensitive detector dimension, the distribution
shows a peak corresponding to the alignment centred over the sample.
Fig. 15. Scan over a 2.5×10 mm tumour margin. The red cross refers to
the same scan performed on a smaller 2.5×5 mm2 sample.
